486 related articles for article (PubMed ID: 26322680)
1. AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest.
Doménech E; Maestre C; Esteban-Martínez L; Partida D; Pascual R; Fernández-Miranda G; Seco E; Campos-Olivas R; Pérez M; Megias D; Allen K; López M; Saha AK; Velasco G; Rial E; Méndez R; Boya P; Salazar-Roa M; Malumbres M
Nat Cell Biol; 2015 Oct; 17(10):1304-16. PubMed ID: 26322680
[TBL] [Abstract][Full Text] [Related]
2. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
[TBL] [Abstract][Full Text] [Related]
3. AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases.
Wu SB; Wei YH
Biochim Biophys Acta; 2012 Feb; 1822(2):233-47. PubMed ID: 22001850
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin requires AMPK activity and p27 expression for promoting autophagy-dependent Tsc2-null cell survival.
Campos T; Ziehe J; Fuentes-Villalobos F; Riquelme O; Peña D; Troncoso R; Lavandero S; Morin V; Pincheira R; Castro AF
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1200-7. PubMed ID: 26975583
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
[TBL] [Abstract][Full Text] [Related]
6. AMPK-autophagy inhibition sensitizes icaritin-induced anti-colorectal cancer cell activity.
Zhou C; Gu J; Zhang G; Dong D; Yang Q; Chen MB; Xu D
Oncotarget; 2017 Feb; 8(9):14736-14747. PubMed ID: 28103582
[TBL] [Abstract][Full Text] [Related]
7. PFKFB3 potentially contributes to paclitaxel resistance in breast cancer cells through TLR4 activation by stimulating lactate production.
Ge X; Cao Z; Gu Y; Wang F; Li J; Han M; Xia W; Yu Z; Lyu P
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):119-25. PubMed ID: 27262815
[TBL] [Abstract][Full Text] [Related]
8. Oleanolic acid induces metabolic adaptation in cancer cells by activating the AMP-activated protein kinase pathway.
Liu J; Zheng L; Wu N; Ma L; Zhong J; Liu G; Lin X
J Agric Food Chem; 2014 Jun; 62(24):5528-37. PubMed ID: 24856665
[TBL] [Abstract][Full Text] [Related]
9. AMP-activated kinase (AMPK) regulates activity of HER2 and EGFR in breast cancer.
Jhaveri TZ; Woo J; Shang X; Park BH; Gabrielson E
Oncotarget; 2015 Jun; 6(17):14754-65. PubMed ID: 26143491
[TBL] [Abstract][Full Text] [Related]
10. Positive regulation of PFKFB3 by PIM2 promotes glycolysis and paclitaxel resistance in breast cancer.
Lu C; Qiao P; Sun Y; Ren C; Yu Z
Clin Transl Med; 2021 Apr; 11(4):e400. PubMed ID: 33931981
[TBL] [Abstract][Full Text] [Related]
11. AMP-activated protein kinase is dispensable for maintaining ATP levels and for survival following inhibition of glycolysis, but promotes tumour engraftment of Ras-transformed fibroblasts.
Pelletier J; Roux D; Viollet B; Mazure NM; Pouysségur J
Oncotarget; 2015 May; 6(14):11833-47. PubMed ID: 26059436
[TBL] [Abstract][Full Text] [Related]
12. A role for inducible 6-phosphofructo-2-kinase in the control of neuronal glycolysis.
Li H; Guo X; Xu H; Woo SL; Halim V; Morgan C; Wu C
J Nutr Biochem; 2013 Jun; 24(6):1153-8. PubMed ID: 23246158
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of AMPK/autophagy potentiates parthenolide-induced apoptosis in human breast cancer cells.
Lu C; Wang W; Jia Y; Liu X; Tong Z; Li B
J Cell Biochem; 2014 Aug; 115(8):1458-66. PubMed ID: 24619908
[TBL] [Abstract][Full Text] [Related]
14. Loss of PFKFB4 induces cell death in mitotically arrested ovarian cancer cells.
Taylor C; Mannion D; Miranda F; Karaminejadranjbar M; Herrero-Gonzalez S; Hellner K; Zheng Y; Bartholomeusz G; Bast RC; Ahmed AA
Oncotarget; 2017 Mar; 8(11):17960-17980. PubMed ID: 28152500
[TBL] [Abstract][Full Text] [Related]
15. Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance.
Liang J; Xu ZX; Ding Z; Lu Y; Yu Q; Werle KD; Zhou G; Park YY; Peng G; Gambello MJ; Mills GB
Nat Commun; 2015 Aug; 6():7926. PubMed ID: 26272043
[TBL] [Abstract][Full Text] [Related]
16. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
17. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
[TBL] [Abstract][Full Text] [Related]
18. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
20. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion.
Sun ZL; Dong JL; Wu J
Biomed Pharmacother; 2017 Jan; 85():303-312. PubMed ID: 27899257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
